Concept Life Sciences intensifies push into medicinal chemistry with new senior appointment at Peakdale Molecular

Dr Paul Bradley becomes Head of Chemistry at the Sandwich, Kent-based company

Peakdale Molecular, part of the Concept Life Sciences Group, has appointed Dr Paul Bradley as new Head of Chemistry at the company’s Discovery Park site in Sandwich, Kent.

Peakdale Molecular is a UK-based provider of drug discovery services to the pharmaceutical, biotech, diagnostics and materials sciences industries.

Dr Bradley joins the team with experience across multiple therapeutic areas in drug discovery having previously worked for Charnwood Molecular, Pfizer and Knoll Pharmaceuticals.

You may also like

Research & Development

Metrion Biosciences and Peakdale Molecular sign integrated drug discovery partnership

Peakdale Molecular, a UK-based provider of drug discovery services to the pharmaceutical and biotech industries and part of the Concept Life Sciences Group, has signed a collaboration agreement with Metrion Biosciences, a specialist ion channel contract research organisation, to offer complete integrated drug discovery programmes to both new and existing customers for ion channel targets
Research & Development

Peakdale signs collaborative agreement with computational chemistry company Cresset

Cresset delivers software and contract research services which help chemists discover, design and optimise the best small molecules for their project
Research & Development

Centauri Therapeutics extends research partnership with Peakdale Molecular

Peakdale will provide synthetic and analytical chemistry expertise for the continued development of Centauri’s Alphamer platform
Research & Development

Peakdale Molecular enters research collaboration with Pfizer

Peakdale Molecular, a UK research services company, has entered into an agreement with Pfizer in which the company, through its subsidiary Peakdale Chemistry Services, will supply custom synthetic chemistry services to Pfizer at the pharmaceutical company's laboratories in Sandwich, Kent.
Regulatory

US Pharmacopeia details mass spectrometry guidelines to advance biologics impurity control

The new chapter aims to standardise the use of mass spectrometry-based analysis in the biopharmaceutical industry, which can be used to detect impurities in cell and gene therapies, antibodies and other biologics
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Hybrid interferons: developing a novel drug class

With many hurdles to overcome, establishing a new drug candidate is a long process — particularly if you are a smaller biotech company with limited resources. These challenges can be further amplified if the candidate being developed is of an entirely novel drug class
Distribution

2BScientific expands its life science product supply service to Europe with new German facility

The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies
Subscribe now